WALTHAM, Mass.– Trinity Life Sciences, a leader in global life sciences commercialization solutions, announced the winners of the TGaS Advisors Best of Benchmark (BoBs) Awards. The Awards, which are given annually for operational excellence within the pharmaceutical industry, were presented to teams at AbbVie, Astellas Pharma Inc., AstraZeneca, Incyte, Eli Lilly and Company and Novo Nordisk. The BoBs are based on TGaS benchmarking of large, midsize and emerging life sciences companies.
While the specific BoB criteria subtly changes from function to function, the underlying factor for recognition is a pharma operations team that demonstrates the best capability relative to peers in the industry for a specific department, function or process. Winners are chosen based on TGaS benchmarks executed within the prior two calendar years, which gives the TGaS Division a deep understanding of all eligible clients.
“Operations teams play a critical role in pharmaceutical organizations, yet they often go unnoticed as the ‘unsung heroes’ in the industry,” said Gary McWalters, President, TGaS Advisors, a Division of Trinity Life Sciences. “That’s why we are thrilled to acknowledge and celebrate these exceptional teams and the winning companies who have demonstrated superior capabilities that set them apart from their peers. We extend our sincere congratulations to all the winners on their well-deserved recognition.”
Seventh Annual Best of Benchmark Award Winners:
- Commercial Insights: Leadership Excellence – AbbVie
- Field Operations: CRM and Field Technology – Novo Nordisk
- Incentive Compensation Excellence: Incentive Design and Effective IC Management – Novo Nordisk
- Learning & Development: Worldwide Learning: Operations – AstraZeneca
- Marketing Operations: Content Excellence – Eli Lilly and Company
- Omnichannel Marketing: Omnichannel Analytics Excellence – Incyte
- Pricing, Contracting & Analytics: Proposal Development – Astellas Pharma Inc.
- Promotional Review Excellence: Promotional Review Operational & Process Partnership – Novo Nordisk
